Metabolomics in sepsis and its impact on public health

Nikolaos Evangelatos, Pia Bauer, Matthias Reumann, Kapaettu Satyamoorthy, Hans Lehrach, Angela Brand

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Sepsis, with its often devastating consequences for patients and their families, remains a major public health concern that poses an increasing financial burden. Early resuscitation together with the elucidation of the biological pathways and pathophysiological mechanisms with the use of "-omics" technologies have started changing the clinical and research landscape in sepsis. Metabolomics (i.e., the study of the metabolome), an "-omics" technology further down in the "-omics" cascade between the genome and the phenome, could be particularly fruitful in sepsis research with the potential to alter the clinical practice. Apart from its benefit for the individual patient, metabolomics has an impact on public health that extends beyond its applications in medicine. In this review, we present recent developments in metabolomics research in sepsis, with a focus on pneumonia, and we discuss the impact of metabolomics on public health, with a focus on free/libre open source software.

Original languageEnglish
Pages (from-to)274-285
Number of pages12
JournalPublic Health Genomics
Volume20
Issue number5
DOIs
Publication statusPublished - 01-04-2018

Fingerprint

Metabolomics
Sepsis
Public Health
Research
Technology
Metabolome
Resuscitation
Pneumonia
Software
Medicine
Genome

All Science Journal Classification (ASJC) codes

  • Public Health, Environmental and Occupational Health
  • Genetics(clinical)

Cite this

Evangelatos, Nikolaos ; Bauer, Pia ; Reumann, Matthias ; Satyamoorthy, Kapaettu ; Lehrach, Hans ; Brand, Angela. / Metabolomics in sepsis and its impact on public health. In: Public Health Genomics. 2018 ; Vol. 20, No. 5. pp. 274-285.
@article{4748d61b1d2e4e539bf2b6b743ef4c5d,
title = "Metabolomics in sepsis and its impact on public health",
abstract = "Sepsis, with its often devastating consequences for patients and their families, remains a major public health concern that poses an increasing financial burden. Early resuscitation together with the elucidation of the biological pathways and pathophysiological mechanisms with the use of {"}-omics{"} technologies have started changing the clinical and research landscape in sepsis. Metabolomics (i.e., the study of the metabolome), an {"}-omics{"} technology further down in the {"}-omics{"} cascade between the genome and the phenome, could be particularly fruitful in sepsis research with the potential to alter the clinical practice. Apart from its benefit for the individual patient, metabolomics has an impact on public health that extends beyond its applications in medicine. In this review, we present recent developments in metabolomics research in sepsis, with a focus on pneumonia, and we discuss the impact of metabolomics on public health, with a focus on free/libre open source software.",
author = "Nikolaos Evangelatos and Pia Bauer and Matthias Reumann and Kapaettu Satyamoorthy and Hans Lehrach and Angela Brand",
year = "2018",
month = "4",
day = "1",
doi = "10.1159/000486362",
language = "English",
volume = "20",
pages = "274--285",
journal = "Public Health Genomics",
issn = "1662-4246",
publisher = "S. Karger AG",
number = "5",

}

Metabolomics in sepsis and its impact on public health. / Evangelatos, Nikolaos; Bauer, Pia; Reumann, Matthias; Satyamoorthy, Kapaettu; Lehrach, Hans; Brand, Angela.

In: Public Health Genomics, Vol. 20, No. 5, 01.04.2018, p. 274-285.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Metabolomics in sepsis and its impact on public health

AU - Evangelatos, Nikolaos

AU - Bauer, Pia

AU - Reumann, Matthias

AU - Satyamoorthy, Kapaettu

AU - Lehrach, Hans

AU - Brand, Angela

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Sepsis, with its often devastating consequences for patients and their families, remains a major public health concern that poses an increasing financial burden. Early resuscitation together with the elucidation of the biological pathways and pathophysiological mechanisms with the use of "-omics" technologies have started changing the clinical and research landscape in sepsis. Metabolomics (i.e., the study of the metabolome), an "-omics" technology further down in the "-omics" cascade between the genome and the phenome, could be particularly fruitful in sepsis research with the potential to alter the clinical practice. Apart from its benefit for the individual patient, metabolomics has an impact on public health that extends beyond its applications in medicine. In this review, we present recent developments in metabolomics research in sepsis, with a focus on pneumonia, and we discuss the impact of metabolomics on public health, with a focus on free/libre open source software.

AB - Sepsis, with its often devastating consequences for patients and their families, remains a major public health concern that poses an increasing financial burden. Early resuscitation together with the elucidation of the biological pathways and pathophysiological mechanisms with the use of "-omics" technologies have started changing the clinical and research landscape in sepsis. Metabolomics (i.e., the study of the metabolome), an "-omics" technology further down in the "-omics" cascade between the genome and the phenome, could be particularly fruitful in sepsis research with the potential to alter the clinical practice. Apart from its benefit for the individual patient, metabolomics has an impact on public health that extends beyond its applications in medicine. In this review, we present recent developments in metabolomics research in sepsis, with a focus on pneumonia, and we discuss the impact of metabolomics on public health, with a focus on free/libre open source software.

UR - http://www.scopus.com/inward/record.url?scp=85040975215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040975215&partnerID=8YFLogxK

U2 - 10.1159/000486362

DO - 10.1159/000486362

M3 - Review article

VL - 20

SP - 274

EP - 285

JO - Public Health Genomics

JF - Public Health Genomics

SN - 1662-4246

IS - 5

ER -